Evidence map›Paper›PMID 10581318›Full record

ArticleThe Journal of physiology1999

Dynamic Ca2+ signalling in rat arterial smooth muscle cells under the control of local renin-angiotensin system.

Y Asada, T Yamazawa, K Hirose, T Takasaka, M Iino

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. NaEuropean journal of pharmacology · 2021
    Article
  3. Review
  4. Article
  5. Inositol trisphosphate receptors in smooth muscle cells.American journal of physiology. Heart and circulatory physiology · 2012
    Review
  6. Article
  7. Mechanisms underlying angiotensin II-induced calcium oscillations.American journal of physiology. Renal physiology · 2008
    Article
  8. Smooth muscle sparklet Ca(v) channels defined: 1.2 is the number.American journal of physiology. Heart and circulatory physiology · 2007
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Y AsadaDepartment of Pharmacology, Graduate School of Medicine, The University of Tokyo, Japan.
T Yamazawa
K Hirose
T Takasaka
M Iino
The University of Tokyo · JPJapan Science and Technology Agency · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1. We visualized the changes in intracellular Ca2+ concentration ([Ca2+]i), using fluo-3 as an indicator, in individual smooth muscle cells within intact rat tail artery preparations. 2. On average in about 45 % of the vascular smooth muscle cells we found spontaneous Ca2+ waves and oscillations ( approximately 0.13 Hz), which we refer to here as Ca2+ ripples because the peak amplitude of [Ca2+]i was about one-seventh of that of Ca2+ oscillations evoked by noradrenaline. 3. We also found another pattern of spontaneous Ca2+ transients often in groups of two to three cells. They were rarely observed and are referred to as Ca2+ flashes because their peak amplitude was nearly twice as large as that in noradrenaline-evoked responses. 4. Sympathetic nerve activity was not considered responsible for the Ca2+ ripples, and they were abolished by inhibitors of either the Ca2+ pump in the sarcoplasmic reticulum (cyclopiazonic acid) or phospholipase C (U-73122). 5. Both angiotensin antagonists ([Sar1,Ile8]-angiotensin II and losartan) and an angiotensin converting enzyme inhibitor (captopril) inhibited the Ca2+ ripples. 6. The extracellular Ca2+-dependent tension borne by unstimulated arterial rings was reduced by the angiotensin antagonist by approximately 50 %. 7. These results indicate that the Ca2+ ripples are generated via inositol 1,4, 5-trisphosphate-induced Ca2+ release from the intracellular Ca2+ stores in response to locally produced angiotensin II, which contributes to the maintenance of vascular tone.

Indexed as

1-Sarcosine-8-Isoleucine Angiotensin IIAngiotensin-Converting Enzyme InhibitorsAniline CompoundsAnimalsAntihypertensive AgentsArteriesCalciumCalcium SignalingCalcium-Transporting ATPasesCaptoprilEnzyme InhibitorsEstrenesEvoked PotentialsFluorescent DyesIndolesLosartan1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione1-Sarcosine-8-Isoleucine Angiotensin IIAngiotensin-Converting Enzyme InhibitorsAniline CompoundsAntihypertensive AgentsCalciumCalcium-Transporting ATPasesCaptoprilcyclopiazonic acidEnzyme InhibitorsEstrenesFluo-3Fluorescent DyesIndolesLosartanPhosphodiesterase InhibitorsPyrrolidinonesType C PhospholipasesXanthenes

Identifiers

PMID10581318
PMCPMC2269666
OpenAlexW2070010310

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.